James Kelly
Förmögenhet: 1 M $ per 2026-05-31
Förmögenhet: 1 M $ per 2026-05-31
Mr. James P.
Kelly, CFA MBA, is a Chief Financial Officer, Treasurer & Executive VP at Novavax, Inc. and a Member at The Association of Bioscience Financial Officers.
Mr. Kelly was previously employed as a Chief Financial Officer & Executive Vice President by Supernus Pharmaceuticals, Inc., a Chief Financial Officer, Treasurer & Executive VP by Vanda Pharmaceuticals, Inc., a Vice President & Controller by MedImmune LLC, a Director-Planning & Operations by Biogen Idec, Inc., and a Principal by Aetna, Inc. He received his undergraduate degree from the University of Vermont and an MBA from Cornell University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NOVAVAX, INC. 0,08 % | 2026-04-23 | 130 599 ( 0,08 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| NOVAVAX, INC. | Finansdirektör/CFO | 2021-08-16 |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2021-08-13 |
| VANDA PHARMACEUTICALS INC. | Finansdirektör/CFO | 2020-03-15 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Revisor | 2010-12-01 |
| BIOGEN INC. | Företagsledare/Principal | 2005-11-01 |
| AETNA | Företagsledare/Principal | 2000-06-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novavax, Inc.
Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Aetna, Inc.
Aetna, Inc. Managed Health CareHealth Services Provides health insurance plans services | Health Services |
Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån